Abstract

Cachexia is a debilitating syndrome that complicates the management of cancer patients. Muscle wasting, one of the main features of cachexia, is associated with hyper-activation of protein degradative pathways and altered mitochondrial function that could both result from impaired redox homeostasis. This study aimed to investigate the contribution of oxidative stress to cancer-induced cachexia in the presence or in the absence of moderate exercise training. Mice bearing the colon C26 carcinoma, either sedentary or exercised, were used. The former showed muscle wasting and redox imbalance, with the activation of an antioxidant response and with upregulation of markers of proteasome-dependent protein degradation and autophagy. Moderate exercise was able to relieve muscle wasting and prevented the loss of muscle strength; such a pattern was associated with reduced levels of Reactive Oxygen Species (ROS), carbonylated proteins and markers of autophagy and with improved antioxidant capacity. The muscle of sedentary tumor hosts also showed increased levels of molecular markers of mitophagy and reduced mitochondrial mass. Conversely, exercise in the C26 hosts led to increased mitochondrial mass. In conclusion, moderate exercise could be an effective non-pharmacological approach to prevent muscle wasting in cancer patients, decreasing muscle protein catabolism and oxidative stress and preserving mitochondria.

Highlights

  • Cancer cachexia is a complex syndrome characterized by body weight loss, muscle wasting and metabolic alterations that occurs in 50–80% of advanced malignant tumors, accounting for about 20% of cancer patient deaths [1]

  • The results show that moderate exercise is able to relieve muscle wasting and oxidative stress in tumor hosts, while only the former is improved in the presence of chemotherapy

  • The possible accumulation of oxidized products that derives from oxidative stress could be counterbalanced by the active catabolism in cachectic animals

Read more

Summary

Introduction

Cancer cachexia is a complex syndrome characterized by body weight loss, muscle wasting and metabolic alterations that occurs in 50–80% of advanced malignant tumors, accounting for about 20% of cancer patient deaths [1]. Muscle wasting is one of the main clinical events and negatively correlates with anticancer treatment tolerance and effectiveness, resulting in reduced patient survival [2,3]. Hypoanabolism and mitochondrial alterations may contribute to cancer cachexia [5,6,7]. In the skeletal muscle, a reduced number of mitochondria and impaired mitophagy correlate with loss of mass and function in both experimental and human cancer cachexia [5,8].

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call